Tsui,
Evaluation of epigenetic and single-cell approaches for cancer genomic analysis: potential for non-invasive cancer diagnostics University of Cambridge 01/06/2015
Tucker, Dr Elizabeth lizzie.tucker**[ta]**.ac.uk
An investigation into the treatment of neuroblastoma with mutations of Anaplastic Lymphoma Kinase (ALK), using LDK378 and LEE011 combination therapy targeting ALK and Cyclin-dependent Kinase (CDK) 4/6, in a preclinical transgenic neuroblastoma model Institute of Cancer Research 01/09/2015
Turajlic, Dr Samra Mapping clonal evolution in renal cell carcinoma The Francis Crick Institute 01/09/2014
Turner, Professor Bryan b.m.turner**[ta]**m.ac.uk
Exploring the metaphase epigenome in normal and leukaemic cells University of Birmingham 01/06/2012
Defning an early transcriptional response to histone deacetylase inhibitors: regulation by chromatin and effects on cell survival.University of Birmingham 01/04/2012
Turner, Dr Nicholas nicholas.turner**[ta]**.ac.uk
Targeting aberrant fbroblast growth factor receptor signalling in cancer Institute of Cancer Research 01/09/2013
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.CRUK/15/010:plasmaMATCH:A multiple parallel cohort,non-randomised,open label,multicentre phaseIIa clinical trial aiming to provide proof of principle efcacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identifed through ctDNA screening Institute of Cancer Research 01/09/2015
Uhlmann, Dr Frank frank.uhlmann**[ta]**ck.ac.uk
Chromosome Segregation Laboratory The Francis Crick Institute 01/10/2012
Usher-Smith, Dr Juliet jau20**[ta]**schl.cam.ac.uk
Developing personalised cancer risk information to promote behaviour change.University of Cambridge 01/04/2015
Valeri, Dr Nicola Targeting microRNAs driving colon carcinogenesis Institute of Cancer Research 01/12/2013
Valle, Professor Juan juan.valle**[ta]**istie.nhs.uk
CRUK/13/004: ABC-06: A randomised phase III, multicentre, open-label study of Active Symptom Control (ASC) alone or ASC with oxaliplatin/5-FU CT for patients with locally advanced/metastatic biliary tract cancers previously treated with cisplatin/gemcitabine CT (supported by Stand Up To Cancer) University of Manchester 01/09/2013
Van Loo, Dr Peter QQR NULL 01/01/2015
van Werven, Dr Folkert Cell Fate and Gene Regulation The Francis Crick Institute 01/11/2013
Vanhaesebroeck, Professor Bart bart.vanh**[ta]**.ac.uk
PI 3-kinase isoforms in
Vazquez, Dr Alexei QQR Cancer Research UK Beatson Institute 01/01/2015
Velikova, Professor Galina g.velikova**[ta]**ds.ac.uk
Real-time Electronic Patient Outcome ReporTing of adverse events in UK cancer trials (REPORT UK) University of Leeds 01/01/2013
Vidal, Dr Marcos m.vidal**[ta]**tson.gla.ac.uk
Drosophila Approaches to Cancer Cancer Research UK Beatson Institute 01/04/2009
Vojnovic, Professor Boris boris.vojnovic**[ta]**ology.ox.ac.uk
Advanced Technology and Radiation Biology Cancer Research UK/ MRC Oxford Institute for Radiation Oncology 01/07/2012
The above is a list of Cancer Research
Identifying demographic and psychosocial predictors of flexible sigmoidoscopy screening intentions and
Vormoor, Professor Josef josef.vormoor**[ta]**.ac.uk
Understanding and Exploiting Stemness in Childhood Acute Lymphoblastic
Vousden, Professor Karen k.vousden**[ta]**tson.gla.ac.uk
CRUK Beatson Institute Drug Discovery Programme Cancer Research UK Beatson Institute 01/04/2014
Cancer Research UK Beatson Institute Core Grant Cancer Research UK Beatson Institute (Core Grants) 01/04/2013
Tumour Suppression Cancer Research UK Beatson Institute 01/03/2014
Wadsley, Dr Jonathan jonathan.wadsley**[ta]**.nhs.uk
CRUK/14/041 SEL-I-METRY: Investigating the potential clinical beneft of selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy Shefeld Teaching Hospitals NHS Foundation Trust 01/02/2015
Walabyeki, Dr Julie Julie.Walabyeki**[ta]**s.ac.uk
Age linked factors and help seeking behaviour: a qualitative study exploring the effect of older people’s fatalistic attitudes towards ill health and dying University of Hull 01/02/2015
Walczak, Professor Henning h.walczak**[ta]**.ac.uk
Understanding and harnessing TRAIL's protumourigenic and pro-apoptotic in-vivo functions for improved cancer
Wald, Professor Sir Nicholas n.j.wald**[ta]**l.ac.uk
CRUK/96/012: Helicobacter pylori screening study: a randomised stomach cancer prevention trial Queen Mary, University of London 01/01/2014
Waller, Dr Jo j.waller**[ta]**.ac.uk
Using behavioural science to maximise the impact of cervical cancer control policies University College London 01/01/2015
Wardle, Professor Jane j.wardle**[ta]**.ac.uk
Developing and testing targeted invitation materials to increase uptake of lung cancer screening in communities at high risk of lung cancer University College London 01/10/2014
Energy Balance and
Cancer Communication and Screening University College London 01/04/2012
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Wasan, Dr Harpreet Molecular classifcation of carcinomas of unknown primary (CUP): Diagnostic validation and correlation with clinical outcomes with epirubicin, cisplatin, capecitabine Imperial College London 01/01/2012
Wason, Dr James james.wason**[ta]**-bsu.cam.ac.uk
Improving the power of phase II oncology trials through the use of continuous tumour measurements Medical Research Council Centre - Cambridge 01/01/2015
Improving the intra-operative diagnosis of high-grade glioma using a fluorescence
Waugh, Professor David d.waugh**[ta]**.ac.uk
Research Resource - A national digital pathology and image analysis platform for solid tumours, complemented by a comprehensive Clinical Fellowship programme in Molecular Pathology.Queen's University Belfast 01/07/2015
Way, Dr Michael michael.way**[ta]**ck.ac.uk
Michael Way 2007-2011 Quinquennial review The Francis Crick Institute 01/03/2012
Wearden, Professor Alison alison.wearden**[ta]**chester.ac.uk
Support to develop cancer-related health behaviour expertise in Manchester University of Manchester 01/09/2013
Wedge, Professor Steve steve.wedge**[ta]**castle.ac.uk
The Cancer Research
Welburn, Dr Julie julie.welburn**[ta]**ac.uk
Function and regulatory mechanisms of kinesin holocomplexes in mitosis University of Edinburgh 01/05/2012
Weller, Professor David david.weller**[ta]**ac.uk
Understanding how ‘lung cancer symptoms’ and ‘service’ factors drive the decision to seek help from a GP in the Scottish public: a discrete choice experiment University of Edinburgh 01/12/2014
West, Professor Catharine CRUK/14/030 Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy (RAPPER)-3 University of Manchester 01/08/2014
Prospective qualifcation of a hypoxia metagene biomarker in a randomised placebo controlled trial of synchronous NIMorazole versus RADiotherapy alone in patients with locally advanced head and neck squamous cell carcinoma not suitable for synchronous chemotherapy or cetuximab (NIMRAD-METAGENE) University of Manchester 01/08/2014
West, Professor Robert robert.west**[ta]**.ac.uk
Smoking cessation: population and clinical approaches University College London 01/04/2012
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.West, Dr Stephen Genetic Recombination Laboratory The Francis Crick Institute 01/11/2010
Wheatley, Professor Keith k.wheatley**[ta]**m.ac.uk
CRUK/11/056: A randomized phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma - BEACON-Neuroblastoma Trial University of Birmingham 01/01/2013
CRUK/11/050: International Randomised Controlled Trial for the Treatment of Newly Diagnosed Ewing's Sarcoma Family of Tumours (Euro Ewing's 2012 - EE2012)
Whitaker, Dr Katriina k.whitaker**[ta]**rey.ac.uk
Understanding socioeconomic differences in helpseeking for breast cancer symptoms in the UK University of Surrey 01/12/2014
Cancer symptom appraisal in everyday life: psychological and demographic influences University of Surrey 01/04/2012
Whitehouse, Professor Adrian a.whitehouse**[ta]**ds.ac.uk
Next generation antivirals for the treatment of Kaposi’s sarcoma University of Leeds 01/08/2015
Whitfeld, Dr Gillian gillian.whitfeld**[ta]**istie.nhs.uk
CRUK/13/017: A randomized phase II trial of Hippocampal Sparing versus Conventional Whole Brain Radiotherapy after surgical resection or radiosurgery in favourable prognosis patients with 1-4 brain metastases (jointly funded by The Brain Tumour Charity) University College London 01/03/2014
Wigley, Professor Dale d.wigley**[ta]**erial.ac.uk
The structure and mechanism of proteins involved in double-strand DNA break repair Imperial College London 01/04/2011
Wilkinson, Dr Simon s.wilkinson**[ta]**ac.uk
TBK1 kinase addiction in KRAS-dependent non-small cell lung cancer: the role of
Winton, Dr Douglas Stem Cell Biology of the Intestine Cancer Research UK Cambridge Institute 01/10/2012
Wolf, Professor Roland c.r.wolf**[ta]**dee.ac.uk
Molecular and pharmacological characterisation of pathways which determine the sensitivity of cells to anti-cancer drugs and chemopreventive agents University of Dundee 01/07/2011
Salary for Ms Aileen McLaren on Professor Roland Wolf's Programme grant C4639/A10822 University of Dundee 01/07/2011
The above is a list of Cancer Research
CRUKD/11/005: SCART - Phase I/II study of the oral MEK inhibitor Selumetinib (AZD6244) in Combination with Highly Active Anti-Retroviral Therapy (HAART) in Kaposi's Sarcoma (KS) (AZ/NCRN) University of Shefeld 01/03/2012
Woods, Dr Laura laura.woods**[ta]**tm.ac.uk
The determinants of international and socio-economic variations in female breast cancer survival London School of Hygiene and Tropical Medicine 01/04/2009
Wright, Professor Sir Nicholas n.a.wright**[ta]**l.ac.uk
Colorectal adenomas, Barretts oesophagus, colitisassociated cancer Queen Mary, University of London 01/05/2012
CRUKD/14/004 ComPAKT A Phase I multi-centre trial of the combination of AZD5363 (AKT inhibitor) and olaparib (PARP inhibitor) in patients with advanced solid tumours Institute of Cancer Research 01/07/2014
Yardimci, Dr Hasan Single Molecule Imaging The Francis Crick Institute 01/09/2013
Yong, Professor Kwee kwee.yong**[ta]**.ac.uk
CRUKE/13/032: CARDAMON: Carflzomib/ Cyclophosphamide/Dexamethasone with maintenance carflzomib in untreated transplanteligible patients with symptomatic MM to evaluate the beneft of upfront ASCT University College London 01/04/2015
Sequencing approaches to discover markers of response and relapse following Carflzomib therapy for newly diagnosed patients with multiple myeloma University College London 01/09/2015
Young, Professor Kenneth ken.young**[ta]**.net OPTIMAM2: Optimisation of breast cancer detection using digital X-ray technology The Royal Surrey County Hospital 01/12/2013
Zanivan, Dr Sara s.zanivan**[ta]**tson.gla.ac.uk
Vascular Proteomics Cancer Research UK Beatson Institute 01/10/2010
Ziebland, Professor Sue sue.ziebland**[ta]**.ox.ac.uk
A comparative qualitative study of patients’ experiences of cancer diagnosis in
- 項目對接快訊
-
- 最新信息
- 熱門信息
